Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.

Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
14 01 2019
Historique:
received: 28 12 2018
accepted: 28 12 2018
entrez: 16 1 2019
pubmed: 16 1 2019
medline: 16 1 2019
Statut: epublish

Résumé

Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected.

Identifiants

DOI: 10.1186/s13063-018-3155-9 PMID: 30642386 PMC: PMC6332521
pubmed: 30642386
doi: 10.1186/s13063-018-3155-9
pii: 10.1186/s13063-018-3155-9
pmc: PMC6332521
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Pagination

48

Subventions

Organisme : FIC NIH HHS
ID : D43 TW010060
Pays : United States
Organisme : Medical Research Council
ID : MC_PC_MR/P006922/1
Pays : United Kingdom

Commentaires et corrections

Type : ErratumFor

Références

Trials. 2018 Nov 23;19(1):649
pubmed: 30470259

Auteurs

David S Lawrence (DS)

Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK. david.s.lawrence@lshtm.ac.uk.
Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana. david.s.lawrence@lshtm.ac.uk.

Nabila Youssouf (N)

Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.

Síle F Molloy (SF)

Research Centre for Infection and Immunity, St George's University of London, London, UK.

Alexandre Alanio (A)

Molecular Mycology Unit and National Reference Centre for Invasive Mycoses, Institut Pasteur, Paris, France.

Melanie Alufandika (M)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.

David R Boulware (DR)

Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Department of Medicine, University of Minnesota, Minneapolis, MN, USA.

Timothée Boyer-Chammard (T)

Molecular Mycology Unit and National Reference Centre for Invasive Mycoses, Institut Pasteur, Paris, France.

Tao Chen (T)

Department of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.

Francoise Dromer (F)

Molecular Mycology Unit and National Reference Centre for Invasive Mycoses, Institut Pasteur, Paris, France.

Admire Hlupeni (A)

Department of Medicine, University of Zimbabwe College of Health Sciences, Parirenyatwa Hospital, Harare, Zimbabwe.

William Hope (W)

Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.

Mina C Hosseinipour (MC)

Lilongwe Medical Relief Trust (UNC Project), Lilongwe, Malawi.

Cecilia Kanyama (C)

Lilongwe Medical Relief Trust (UNC Project), Lilongwe, Malawi.

Oliver Lortholary (O)

Molecular Mycology Unit and National Reference Centre for Invasive Mycoses, Institut Pasteur, Paris, France.

Angela Loyse (A)

Research Centre for Infection and Immunity, St George's University of London, London, UK.

David B Meya (DB)

Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.

Mosepele Mosepele (M)

Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Department of Internal Medicine, University of Botswana, Gaborone, Botswana.

Conrad Muzoora (C)

Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.

Henry C Mwandumba (HC)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.
Department of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.

Chiratidzo E Ndhlovu (CE)

Department of Medicine, University of Zimbabwe College of Health Sciences, Parirenyatwa Hospital, Harare, Zimbabwe.

Louis Niessen (L)

Department of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.

Charlotte Schutz (C)

Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, and Department of Medicine, University of Cape Town, Cape Town, South Africa.

Katharine E Stott (KE)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.
Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.

Duolao Wang (D)

Department of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.

David G Lalloo (DG)

Department of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.

Graeme Meintjes (G)

Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, and Department of Medicine, University of Cape Town, Cape Town, South Africa.

Shabbar Jaffar (S)

Department of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.

Thomas S Harrison (TS)

Research Centre for Infection and Immunity, St George's University of London, London, UK.

Joseph N Jarvis (JN)

Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.

Classifications MeSH